Health ❯ Pharmaceuticals

Medications

GLP-1 Drugs Diabetes Treatment Weight Loss Drugs GLP-1 Semaglutide Ozempic Paracetamol Weight Management Weight Loss Antibiotics

Eli Lilly Pours $4.5 Billion Into Indiana Plants, Opens Genetic-Medicine Site

The buildout strengthens U.S. supply for high‑demand obesity drugs plus diabetes treatments.

Hershey Links Mint and Gum Sales Jump to GLP-1 Drug Use

Brazil Moves to Tighten Rules on GLP‑1 Weight‑Loss Pens as Demand Surges

German Skier Victoria Carl Banned 18 Months After Clenbuterol Positive

Martin Lewis Urges Shoppers To Check PL Codes To Cut Medicine Costs

Brazil Zeroes Import Tariffs on 970 Items, Sets New Antidumping Duties

Semaglutide Patents Lapse in India and China as Safety Scrutiny Rises

Mexico Regulators Warn of Illegal Online Tirzepatide Products

Rio Sets March 18 Launch for Public Semaglutide Care as Supplier Price Survey Opens

Brazil Nears Semaglutide Patent Expiry as Anvisa Reviews 14 Filings and Novo Nordisk Counters

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Málaga Hospital Treats Multiple Teens After 'Paracetamol Challenge'

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

Brazil's Chamber Approves Temporary Tax Cuts for Chemical and Petrochemical Industry

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

Next-Generation Obesity Treatments Gain Traction in 2026 as Brazil Nears Semaglutide Patent Lapse

Trump Defends High-Dose Aspirin Use as Doctor Reports Clear CT Scan

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Cipla Launches Yurpeak in India Under Eli Lilly Supply Deal

Babbel Names 2025’s Most Mispronounced Words, From Mamdani to the Louvre